Arcadia Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.21
|
-0.12
|
0.09
|
42.86%
|
|
2022-06-30
|
-0.30
|
-0.20
|
0.10
|
33.33%
|
|
2022-03-31
|
-0.34
|
-0.20
|
0.14
|
41.18%
|
|
2021-12-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2021-09-30
|
-0.29
|
-0.10
|
0.19
|
65.52%
|
|
2021-06-30
|
-0.27
|
-0.24
|
0.03
|
11.11%
|
|
2021-03-31
|
-0.34
|
0.12
|
0.46
|
135.29%
|
|
2020-12-31
|
-0.41
|
0.88
|
1.29
|
314.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.52
|
|
2021-12-31
|
-0.50
|
|
2020-12-31
|
-0.47
|
|
2019-12-31
|
-4.34
|
|
2018-12-31
|
-6.09
|
|
2017-12-31
|
-7.39
|
|
2016-12-31
|
-8.80
|
|
2015-12-31
|
-5.61
|